“3 “Strong Buy” Stocks Under $10 With Triple-Digit Upside Potential”
May 27, 2021
“RedHill Biopharma (RDHL)…
Overall, based on all the above factors, Wall Street analysts are thoroughly impressed with RDHL. It boasts 100% Street support, or 4 Buy ratings in the last three months, making the consensus a Strong Buy. Shares are selling for $6.94 each, and the average target of $20.50 indicates a possible upside of 195% by next year…
Freeline Therapeutics (FRLN)…
Trucchio is not alone in taking a bullish view here; there are 6 recent reviews of this stock and all are positive, making for a unanimous Strong Buy consensus rating. The shares are priced at $8.41 with an average price target of $24.50 implying an upside of 191%…
Clene (CLNN)…
In its short time on the public markets, CLNN has attracted 4 analyst reviews – and all are positive, making the analyst consensus a Strong Buy. The stock has an average price target of $22.25, suggesting a 131% one-year upside from current levels…”
https://finance.yahoo.com/news/3-strong-buy-stocks-under-150607876.html